search
Back to results

Hypertonic Resuscitation Following Traumatic Injury

Primary Purpose

Shock, Traumatic

Status
Terminated
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
7.5% hypertonic saline/6% Dextran-70 (HSD)
7.5% hypertonic saline (HS)
0.9% normal saline
Sponsored by
University of Washington
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Shock, Traumatic focused on measuring Trauma, Shock

Eligibility Criteria

15 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Blunt or penetrating trauma Prehospital Systolic Blood Pressure (SBP) <= 70;OR Prehospital SBP 71-90 AND Hear Rate (HR) ≥108 15 years of age or older, or 50kg or more if age unknown Exclusion Criteria: Known or suspected pregnancy Age younger than 15 or less than 50kg if age unknown Ongoing prehospital cardiopulmonary resuscitation (CPR) Administration of more than 2000cc crystalloid or any colloid or blood products Severe hypothermia (suspected Temperature less than 28 degrees celsius) Drowning or asphyxia due to hanging Burns Total Body Surface Area (TBSA) more than 20% Isolated penetrating injury to the head Inability to obtain prehospital intravenous access Time of call received at dispatch to study intervention greater than four hours Known prisoners

Sites / Locations

  • Alabama Resuscitaion Center, University of Alabama
  • UCSD-San Diego Resuscitation Research Center
  • Iowa Resuscitation Network, University of Iowa Carver College of Medicine
  • Portland Resuscitation Outcomes Consortium, Oregon Health & Sciences University
  • The Pittsburgh Resuscitation Network, University of Pittsburgh
  • Dallas Center for Resuscitation Research, University of Texas Southwestern Medical Center
  • Seattle-King County Center For Resuscitation Research, University of Washington
  • Milwaukee Resuscitation Network, Medical College of Wisconsin
  • University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Institute
  • Toronto Regional Resuscitation Research Out-of-Hospital Network, University of Toronto

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Placebo Comparator

Arm Label

1

2

3

Arm Description

7.5% hypertonic saline/6% Dextran-70 (HSD)

7.5% hypertonic saline (HS)

0.9% normal saline

Outcomes

Primary Outcome Measures

28 Day Survival
The day of episode is counted as "Day 0". So for measures using a 28 day period, the maximum value is 29 (i.e. days 0 through 28).

Secondary Outcome Measures

Adult Respiratory Distress Syndrome(ARDS)-Free Survival Through Day 28
Absence of diagnosis of Adult Respiratory Distress Syndrome and alive through day 28
Worst Multiple Organ Dysfunction Score (MODS) Mean Through Day 28
Multiple Organ Dysfunction Score is described as: Six organ systems were chosen, and a score of 0-4 allotted for each organ according to function (0 being normal function through to 4 for most severe dysfunction) with a maximum score of 24. The worst score based on available data (missing values were assumed normal) in each 24-hour period is taken for calculation of the aggregate score.
Presence of Nosocomial Infection Through Day 28
Includes one or more nosocomial infections from the following list: pneumonia, blood stream infection, urinary tract infection and wound infection
Packed Red Blood Cells (PRBC) First 24 Hours
The numbers of units of packed red blood cells transfused in the first 24 hours
Total Fluids First 24 Hours
The total amount of IV fluids given in the pre-hospital setting and the hospital setting in the first 24 hours following the time of 911 call
Ventilator-free Days Through Day 28
The number of days beginning with the day of 911 call counted as "Day O" through day 28 that the patient did not require mechanical ventilation
Days Alive Out of the Intensive Care Unit (ICU) Through Day 28
The number of days the patient is alive and not being cared for in the intensive care unit
Days Alive Out of the Hospital Through Day 28
The number of days the patient is alive and no longer an inpatient in the hospital through day 28
Survival at Hospital Discharge
Alive at the time of discharge from the Level One or Two trauma hospital. This did not include disposition from rehabilitation facilities.
Zero Units PRBC in First 24 Hours
This is the total number of subjects who received no blood products in the first 24 hours from the time of the 911 call.
Zero Units PRBC and Died in Field or Emergency Department (ED)
This is the total number of subjects who died in the field or the ED from the set of subjects who received no blood products.
Zero Units PRBC and Died Within 6 Hours of Admission to the Hospital
This is the total number of subjects who died within the first 6 hours from the time of admission to the hospital among the patients who received no blood products.
Zero Units PRBC and Died Within 28 Days From the Time of the 911 Call
This is the total number of subjects who died within 28 days from the time of the 911 call among the patients who received no units of PRBC.
1-9 Units PRBC in First 24 Hours
This is the total number of subjects who received 1 to 9 units of packed red blood cells (PRBC) in the first 24 hours from the time of the 911 call.
1-9 Units PRBC and Died in Field or ED
This is the total number of subjects who received 1 to 9 units of packed red blood cells (PRBC) among the patients who died in the field or the ED.
1-9 Units PRBC and Died Within 6 Hours of Admission to the Hospital
This is the total number of subjects who died within the first 6 hours from the time of admission to the hospital among the patients who received 1 to 9 units of packed red blood cells (PRBC).
1-9 Units PRBC and Died Within 28 Days From the Time of the 911 Call
This is the total number of subjects who died within 28 days from the time of the 911 call among the patients who received 1 to 9 units of packed red blood cells (PRBC).
Greater Than 10 Units PRBC in First 24 Hours
This is the total number of subjects who received greater than 10 units of packed red blood cells (PRBC) in the first 24 hours from the time of the 911 call.
Greater Than 10 Units PRBC and Died in Field or ED
This is the total number of subjects who died in the field or the ED among the patients who received greater than 10 units of packed red blood cells (PRBC).
Greater Than 10 Units PRBC and Died Within 6 Hours of Admission to the Hospital
This is the total number of subjects who died within the first 6 hours from the time of admission to the hospital among the patients who received greater than 10 units of packed red blood cells (PRBC).
Greater Than 10 Units PRBC and Died Within 28 Days From the Time of the 911 Call
This is the total number of subjects who died within 28 days from the time of the 911 call among the patients who received greater than 10 units of packed red blood cells (PRBC).

Full Information

First Posted
April 17, 2006
Last Updated
February 25, 2011
Sponsor
University of Washington
Collaborators
National Heart, Lung, and Blood Institute (NHLBI), National Institute of Neurological Disorders and Stroke (NINDS), The Institute of Circulatory and Respiratory Health (ICRH), Defence Research and Development Canada
search

1. Study Identification

Unique Protocol Identification Number
NCT00316017
Brief Title
Hypertonic Resuscitation Following Traumatic Injury
Official Title
Phase 3 Study of Hypertonic Resuscitation Following Traumatic Injury With Hypovolemic Shock
Study Type
Interventional

2. Study Status

Record Verification Date
February 2011
Overall Recruitment Status
Terminated
Why Stopped
Futility & potential safety concern (increased early mortality in the HS/HSD arms for those with no PRBC in 1st 24 hr, post-randomization subgp)
Study Start Date
May 2006 (undefined)
Primary Completion Date
August 2009 (Actual)
Study Completion Date
August 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University of Washington
Collaborators
National Heart, Lung, and Blood Institute (NHLBI), National Institute of Neurological Disorders and Stroke (NINDS), The Institute of Circulatory and Respiratory Health (ICRH), Defence Research and Development Canada

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine if hypertonic saline with and without dextran can improve overall survival in victims of trauma with shock. Injury and lost blood from trauma can cause your body to be in shock (low blood pressure related to blood loss). This decreased blood flow can lead to organ damage. In order to restore the blood pressure and blood flow, the medics give fluids into the patients' veins as soon as possible. This is called "resuscitation." The resuscitation fluid most commonly used is "isotonic" or one that is the same concentration as the blood. The investigators are trying to determine if infusing a "hypertonic" fluid (or one more concentrated than the blood) can increase the blood pressure and restore blood flow more efficiently. The hypertonic fluids the investigators are using are called hypertonic saline with dextran (HSD) and hypertonic saline (no dextran). Hypertonic saline is a salt solution that is slightly more concentrated than your blood. Dextran is a sugar solution.
Detailed Description
Specific Aim: To determine if prehospital administration of 7.5% hypertonic saline /6% Dextran-70 (HSD) OR 7.5% hypertonic saline alone (HS), compared to current standard therapy with normal saline (NS), as an initial resuscitation fluid, affects survival following traumatic injury with hypovolemic shock. Trauma is the leading cause of death among North Americans between the ages of 1 and 44 years. The majority of these deaths result from hypovolemic shock or severe brain injury. Patients in hypovolemic shock develop a state of systemic tissue ischemia then a subsequent reperfusion injury at the time of fluid resuscitation. Conventional resuscitation involves the IV administration of a large volume of isotonic or slightly hypotonic (lactated ringers, LR) solutions beginning in the prehospital setting. Although not conclusive, prior studies have suggested that alternative resuscitation with hypertonic saline (7.5%) solutions may reduce morbidity or mortality in these patients. Furthermore, hypertonic fluids may have specific advantages in the brain-injured patient, as they may aid in the rapid restoration of cerebral perfusion and prevent extravascular fluid sequestration, thereby limiting secondary brain injury. In addition, recent studies have demonstrated that hypertonicity significantly alters the activation of inflammatory cells, an effect that may reduce subsequent organ injury from ischemia-reperfusion and decrease nosocomial infection. The majority of previous clinical trials have focused on the use of HSD. The potential for 7.5% saline alone (HS) to have similar effects has not been well studied. Removal of the dextran component may enhance the anti-inflammatory effects of this solution, which could improve secondary outcomes such as acute respiratory distress syndrome (ARDS), multiple organ failure syndrome (MOFS) and rates of nosocomial infections. This study is a randomized, double-blind, three-arm placebo controlled trial designed to evaluate the clinical outcome of trauma patients with hypovolemic shock, as manifested by prehospital hypotension. Patients will be randomized to a single 250cc IV dose of 7.5% saline in 6% Dextran-70 (HSD), 7.5% saline (HS) or normal saline as the initial fluid for prehospital resuscitation. No additional interventions will occur once the patient is admitted to the hospital. In hospital data collection will last up to 28 days.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Shock, Traumatic
Keywords
Trauma, Shock

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
895 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
7.5% hypertonic saline/6% Dextran-70 (HSD)
Arm Title
2
Arm Type
Experimental
Arm Description
7.5% hypertonic saline (HS)
Arm Title
3
Arm Type
Placebo Comparator
Arm Description
0.9% normal saline
Intervention Type
Drug
Intervention Name(s)
7.5% hypertonic saline/6% Dextran-70 (HSD)
Other Intervention Name(s)
RescueFlo
Intervention Description
250 cc dose given as a one-time intravenous (IV) bolus in the pre-hospital setting.
Intervention Type
Drug
Intervention Name(s)
7.5% hypertonic saline (HS)
Intervention Description
250 cc dose given as a one-time IV bolus in the pre-hospital setting.
Intervention Type
Drug
Intervention Name(s)
0.9% normal saline
Intervention Description
250 cc dose given as a one-time IV bolus in the pre-hospital setting.
Primary Outcome Measure Information:
Title
28 Day Survival
Description
The day of episode is counted as "Day 0". So for measures using a 28 day period, the maximum value is 29 (i.e. days 0 through 28).
Time Frame
28 days from time of Emergency Department (ED) arrival
Secondary Outcome Measure Information:
Title
Adult Respiratory Distress Syndrome(ARDS)-Free Survival Through Day 28
Description
Absence of diagnosis of Adult Respiratory Distress Syndrome and alive through day 28
Time Frame
28 days from time of ED arrival
Title
Worst Multiple Organ Dysfunction Score (MODS) Mean Through Day 28
Description
Multiple Organ Dysfunction Score is described as: Six organ systems were chosen, and a score of 0-4 allotted for each organ according to function (0 being normal function through to 4 for most severe dysfunction) with a maximum score of 24. The worst score based on available data (missing values were assumed normal) in each 24-hour period is taken for calculation of the aggregate score.
Time Frame
28 days from time of ED arrival
Title
Presence of Nosocomial Infection Through Day 28
Description
Includes one or more nosocomial infections from the following list: pneumonia, blood stream infection, urinary tract infection and wound infection
Time Frame
Within 28 days of injury, while hospitalized
Title
Packed Red Blood Cells (PRBC) First 24 Hours
Description
The numbers of units of packed red blood cells transfused in the first 24 hours
Time Frame
First 24 hours from the time of 911 call
Title
Total Fluids First 24 Hours
Description
The total amount of IV fluids given in the pre-hospital setting and the hospital setting in the first 24 hours following the time of 911 call
Time Frame
First 24 hours from the time of of 911 call
Title
Ventilator-free Days Through Day 28
Description
The number of days beginning with the day of 911 call counted as "Day O" through day 28 that the patient did not require mechanical ventilation
Time Frame
Duration of hospital stay through day 28
Title
Days Alive Out of the Intensive Care Unit (ICU) Through Day 28
Description
The number of days the patient is alive and not being cared for in the intensive care unit
Time Frame
First 28 days from the time of 911 call
Title
Days Alive Out of the Hospital Through Day 28
Description
The number of days the patient is alive and no longer an inpatient in the hospital through day 28
Time Frame
First 28 days from the time of 911 call
Title
Survival at Hospital Discharge
Description
Alive at the time of discharge from the Level One or Two trauma hospital. This did not include disposition from rehabilitation facilities.
Time Frame
Duration of hospital stay through to discharge
Title
Zero Units PRBC in First 24 Hours
Description
This is the total number of subjects who received no blood products in the first 24 hours from the time of the 911 call.
Time Frame
From the time dispatch received the 911 call to the end of the first 24 hours
Title
Zero Units PRBC and Died in Field or Emergency Department (ED)
Description
This is the total number of subjects who died in the field or the ED from the set of subjects who received no blood products.
Time Frame
From the time dispatch received 911 call to the time of death in the field or ED
Title
Zero Units PRBC and Died Within 6 Hours of Admission to the Hospital
Description
This is the total number of subjects who died within the first 6 hours from the time of admission to the hospital among the patients who received no blood products.
Time Frame
The first 6 hours from the time of admission to the hospital
Title
Zero Units PRBC and Died Within 28 Days From the Time of the 911 Call
Description
This is the total number of subjects who died within 28 days from the time of the 911 call among the patients who received no units of PRBC.
Time Frame
From the time dispatch received the 911 call to 28 days
Title
1-9 Units PRBC in First 24 Hours
Description
This is the total number of subjects who received 1 to 9 units of packed red blood cells (PRBC) in the first 24 hours from the time of the 911 call.
Time Frame
From the time dispatch received the 911 call to the end of the first 24 hours
Title
1-9 Units PRBC and Died in Field or ED
Description
This is the total number of subjects who received 1 to 9 units of packed red blood cells (PRBC) among the patients who died in the field or the ED.
Time Frame
From the time dispatch received 911 call to the time of death in the field or ED
Title
1-9 Units PRBC and Died Within 6 Hours of Admission to the Hospital
Description
This is the total number of subjects who died within the first 6 hours from the time of admission to the hospital among the patients who received 1 to 9 units of packed red blood cells (PRBC).
Time Frame
The first 6 hours from the time of admission to the hospital
Title
1-9 Units PRBC and Died Within 28 Days From the Time of the 911 Call
Description
This is the total number of subjects who died within 28 days from the time of the 911 call among the patients who received 1 to 9 units of packed red blood cells (PRBC).
Time Frame
From the time dispatch received the 911 call to 28 days
Title
Greater Than 10 Units PRBC in First 24 Hours
Description
This is the total number of subjects who received greater than 10 units of packed red blood cells (PRBC) in the first 24 hours from the time of the 911 call.
Time Frame
From the time dispatch received the 911 call to the end of the first 24 hours
Title
Greater Than 10 Units PRBC and Died in Field or ED
Description
This is the total number of subjects who died in the field or the ED among the patients who received greater than 10 units of packed red blood cells (PRBC).
Time Frame
From the time dispatch received 911 call to the time of death in the field or ED
Title
Greater Than 10 Units PRBC and Died Within 6 Hours of Admission to the Hospital
Description
This is the total number of subjects who died within the first 6 hours from the time of admission to the hospital among the patients who received greater than 10 units of packed red blood cells (PRBC).
Time Frame
The first 6 hours from the time of admission to the hospital
Title
Greater Than 10 Units PRBC and Died Within 28 Days From the Time of the 911 Call
Description
This is the total number of subjects who died within 28 days from the time of the 911 call among the patients who received greater than 10 units of packed red blood cells (PRBC).
Time Frame
From the time dispatch received the 911 call to 28 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Blunt or penetrating trauma Prehospital Systolic Blood Pressure (SBP) <= 70;OR Prehospital SBP 71-90 AND Hear Rate (HR) ≥108 15 years of age or older, or 50kg or more if age unknown Exclusion Criteria: Known or suspected pregnancy Age younger than 15 or less than 50kg if age unknown Ongoing prehospital cardiopulmonary resuscitation (CPR) Administration of more than 2000cc crystalloid or any colloid or blood products Severe hypothermia (suspected Temperature less than 28 degrees celsius) Drowning or asphyxia due to hanging Burns Total Body Surface Area (TBSA) more than 20% Isolated penetrating injury to the head Inability to obtain prehospital intravenous access Time of call received at dispatch to study intervention greater than four hours Known prisoners
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Myron L Weisfeldt, MD
Organizational Affiliation
Resuscitation Outcomes Consortium
Official's Role
Study Chair
Facility Information:
Facility Name
Alabama Resuscitaion Center, University of Alabama
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35249
Country
United States
Facility Name
UCSD-San Diego Resuscitation Research Center
City
San Diego
State/Province
California
ZIP/Postal Code
92103
Country
United States
Facility Name
Iowa Resuscitation Network, University of Iowa Carver College of Medicine
City
Iowa City
State/Province
Iowa
ZIP/Postal Code
52242
Country
United States
Facility Name
Portland Resuscitation Outcomes Consortium, Oregon Health & Sciences University
City
Portland
State/Province
Oregon
ZIP/Postal Code
97239
Country
United States
Facility Name
The Pittsburgh Resuscitation Network, University of Pittsburgh
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
Facility Name
Dallas Center for Resuscitation Research, University of Texas Southwestern Medical Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75390
Country
United States
Facility Name
Seattle-King County Center For Resuscitation Research, University of Washington
City
Seattle
State/Province
Washington
ZIP/Postal Code
98195
Country
United States
Facility Name
Milwaukee Resuscitation Network, Medical College of Wisconsin
City
Milwaukee
State/Province
Wisconsin
ZIP/Postal Code
53226
Country
United States
Facility Name
University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Institute
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1Y4E9
Country
Canada
Facility Name
Toronto Regional Resuscitation Research Out-of-Hospital Network, University of Toronto
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5B1W8
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
21178763
Citation
Bulger EM, May S, Kerby JD, Emerson S, Stiell IG, Schreiber MA, Brasel KJ, Tisherman SA, Coimbra R, Rizoli S, Minei JP, Hata JS, Sopko G, Evans DC, Hoyt DB; ROC investigators. Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Ann Surg. 2011 Mar;253(3):431-41. doi: 10.1097/SLA.0b013e3181fcdb22.
Results Reference
result
PubMed Identifier
25072443
Citation
Tisherman SA, Schmicker RH, Brasel KJ, Bulger EM, Kerby JD, Minei JP, Powell JL, Reiff DA, Rizoli SB, Schreiber MA. Detailed description of all deaths in both the shock and traumatic brain injury hypertonic saline trials of the Resuscitation Outcomes Consortium. Ann Surg. 2015 Mar;261(3):586-90. doi: 10.1097/SLA.0000000000000837.
Results Reference
derived

Learn more about this trial

Hypertonic Resuscitation Following Traumatic Injury

We'll reach out to this number within 24 hrs